Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

96 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[YB-1 as a potential target in cancer therapy].
Lage H, Surowiak P, Holm PS. Lage H, et al. Among authors: surowiak p. Pathologe. 2008 Nov;29 Suppl 2:187-90. doi: 10.1007/s00292-008-1030-2. Pathologe. 2008. PMID: 18773210 Review. German.
YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells.
Mantwill K, Naumann U, Seznec J, Girbinger V, Lage H, Surowiak P, Beier D, Mittelbronn M, Schlegel J, Holm PS. Mantwill K, et al. Among authors: surowiak p. J Transl Med. 2013 Sep 18;11:216. doi: 10.1186/1479-5876-11-216. J Transl Med. 2013. PMID: 24044901 Free PMC article.
Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates.
Surowiak P, Materna V, Drag-Zalesinska M, Wojnar A, Kaplenko I, Spaczyński M, Dietel M, Zabel M, Lage H. Surowiak P, et al. Int J Gynecol Pathol. 2006 Apr;25(2):131-9. doi: 10.1097/01.pgp.0000183050.30212.2f. Int J Gynecol Pathol. 2006. PMID: 16633061
Positive correlation between cyclooxygenase 2 and the expression of ABC transporters in non-small cell lung cancer.
Surowiak P, Pawełczyk K, Maciejczyk A, Pudełko M, Kołodziej J, Zabel M, Murawa D, Drag M, Gansukh T, Dietel M, Lage H. Surowiak P, et al. Anticancer Res. 2008 Sep-Oct;28(5B):2967-74. Anticancer Res. 2008. PMID: 19031941
Expression of factors involved in regulation of DNA mismatch repair- and apoptosis pathways in ovarian cancer patients.
Materna V, Surowiak P, Markwitz E, Spaczynski M, Drag-Zalesinska M, Zabel M, Lage H. Materna V, et al. Among authors: surowiak p. Oncol Rep. 2007 Mar;17(3):505-16. Oncol Rep. 2007. PMID: 17273726
Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome.
Surowiak P, Materna V, Maciejczyk A, Pudełko M, Markwitz E, Spaczyński M, Dietel M, Zabel M, Lage H. Surowiak P, et al. Virchows Arch. 2007 Mar;450(3):279-85. doi: 10.1007/s00428-006-0362-7. Epub 2007 Jan 19. Virchows Arch. 2007. PMID: 17235562
Taxol-resistance-associated gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patients.
Materna V, Surowiak P, Kaplenko I, Spaczyński M, Duan Z, Zabel M, Dietel M, Lage H. Materna V, et al. Among authors: surowiak p. Virchows Arch. 2007 Feb;450(2):187-94. doi: 10.1007/s00428-006-0346-7. Virchows Arch. 2007. PMID: 17216190
ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome.
Surowiak P, Materna V, Kaplenko I, Spaczynski M, Dolinska-Krajewska B, Gebarowska E, Dietel M, Zabel M, Lage H. Surowiak P, et al. Clin Cancer Res. 2006 Dec 1;12(23):7149-58. doi: 10.1158/1078-0432.CCR-06-0564. Clin Cancer Res. 2006. PMID: 17145840
Complete reversal of ABCG2-depending atypical multidrug resistance by RNA interference in human carcinoma cells.
Priebsch A, Rompe F, Tönnies H, Kowalski P, Surowiak P, Stege A, Materna V, Lage H. Priebsch A, et al. Among authors: surowiak p. Oligonucleotides. 2006 Fall;16(3):263-74. doi: 10.1089/oli.2006.16.263. Oligonucleotides. 2006. PMID: 16978089
RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells.
Materna V, Stege A, Surowiak P, Priebsch A, Lage H. Materna V, et al. Among authors: surowiak p. Biochem Biophys Res Commun. 2006 Sep 15;348(1):153-7. doi: 10.1016/j.bbrc.2006.07.022. Epub 2006 Jul 14. Biochem Biophys Res Commun. 2006. PMID: 16876126
96 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback